These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 33579873)

  • 21. A Proposed Roadmap for Parkinson's Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein.
    Merchant KM; Cedarbaum JM; Brundin P; Dave KD; Eberling J; Espay AJ; Hutten SJ; Javidnia M; Luthman J; Maetzler W; Menalled L; Reimer AN; Stoessl AJ; Weiner DM;
    J Parkinsons Dis; 2019; 9(1):31-61. PubMed ID: 30400107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Long Way to Go: Patient Perspectives on Digital Health for Parkinson's Disease.
    Riggare S; Stamford J; Hägglund M
    J Parkinsons Dis; 2021; 11(s1):S5-S10. PubMed ID: 33682728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving Cardiovascular Drug and Device Development and Evidence Through Patient-Centered Research and Clinical Trials: A Call to Action From the Value in Healthcare Initiative's Partnering With Regulators Learning Collaborative.
    Warner JJ; Crook HL; Whelan KM; Bleser WK; Roiland RA; Hamilton Lopez M; Saunders RS; Wang TY; Hernandez AF; McClellan MB; Califf RM; Brown N;
    Circ Cardiovasc Qual Outcomes; 2020 Jul; 13(7):e006606. PubMed ID: 32683985
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Digital technologies: Innovations that transform the face of drug development.
    Izmailova ES; AbuAsal B; Hassan HE; Saha A; Stephenson D
    Clin Transl Sci; 2023 Aug; 16(8):1323-1330. PubMed ID: 37157935
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A roadmap for implementation of patient-centered digital outcome measures in Parkinson's disease obtained using mobile health technologies.
    Espay AJ; Hausdorff JM; Sánchez-Ferro Á; Klucken J; Merola A; Bonato P; Paul SS; Horak FB; Vizcarra JA; Mestre TA; Reilmann R; Nieuwboer A; Dorsey ER; Rochester L; Bloem BR; Maetzler W;
    Mov Disord; 2019 May; 34(5):657-663. PubMed ID: 30901495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parkinson's disease biomarkers program brain imaging repository.
    Ofori E; Du G; Babcock D; Huang X; Vaillancourt DE
    Neuroimage; 2016 Jan; 124(Pt B):1120-1124. PubMed ID: 25976927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Co-Designing Digital Technologies for Improving Clinical Care in People with Parkinson's Disease: What Did We Learn?
    Monje MHG; Grosjean S; Srp M; Antunes L; Bouça-Machado R; Cacho R; Domínguez S; Inocentes J; Lynch T; Tsakanika A; Fotiadis D; Rigas G; Růžička E; Ferreira J; Antonini A; Malpica N; Mestre T; Sánchez-Ferro Á; iCARE-Pd Consortium
    Sensors (Basel); 2023 May; 23(10):. PubMed ID: 37430871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effectiveness of internet-based e-learning on clinician behavior and patient outcomes: a systematic review protocol.
    Sinclair P; Kable A; Levett-Jones T
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):52-64. PubMed ID: 26447007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What is the Clinical Significance of Cerebrospinal Fluid Biomarkers in Parkinson's disease? Is the Significance Diagnostic or Prognostic?
    Kim D; Paik JH; Shin DW; Kim HS; Park CS; Kang JH
    Exp Neurobiol; 2014 Dec; 23(4):352-64. PubMed ID: 25548535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Use of Digital Technology and Media in German Parkinson's Disease Patients.
    Marxreiter F; Buttler U; Gassner H; Gandor F; Gladow T; Eskofier B; Winkler J; Ebersbach G; Klucken J
    J Parkinsons Dis; 2020; 10(2):717-727. PubMed ID: 31424420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C-reactive protein as the biomarker of choice to monitor the effects of exercise on inflammation in Parkinson's disease.
    Mehta N; Luthra NS; Corcos DM; Fantuzzi G
    Front Immunol; 2023; 14():1178448. PubMed ID: 37251392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Digital Technology in Movement Disorders: Updates, Applications, and Challenges.
    Adams JL; Lizarraga KJ; Waddell EM; Myers TL; Jensen-Roberts S; Modica JS; Schneider RB
    Curr Neurol Neurosci Rep; 2021 Mar; 21(4):16. PubMed ID: 33660110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surrogate endpoints in Parkinson's disease research.
    Biglan KM; Holloway RG
    Curr Neurol Neurosci Rep; 2003 Jul; 3(4):314-20. PubMed ID: 12930701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers of Parkinson's disease and Dementia with Lewy bodies.
    Henchcliffe C; Dodel R; Beal MF
    Prog Neurobiol; 2011 Dec; 95(4):601-13. PubMed ID: 21983334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel targeted therapies for Parkinson's disease.
    Ntetsika T; Papathoma PE; Markaki I
    Mol Med; 2021 Feb; 27(1):17. PubMed ID: 33632120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can detection and prediction models for Alzheimer's Disease be applied to Prodromal Parkinson's Disease using explainable artificial intelligence? A brief report on Digital Neuro Signatures.
    Tarnanas I; Vlamos P; Harms DR;
    Open Res Eur; 2021; 1():146. PubMed ID: 37645162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Towards early disease modification of Parkinson's disease: a review of lessons learned in the Alzheimer field.
    Smedinga M; Darweesh SKL; Bloem BR; Post B; Richard E
    J Neurol; 2021 Feb; 268(2):724-733. PubMed ID: 32809153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.
    Fereshtehnejad SM; Zeighami Y; Dagher A; Postuma RB
    Brain; 2017 Jul; 140(7):1959-1976. PubMed ID: 28549077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease.
    Meles SK; Oertel WH; Leenders KL
    Mol Med; 2021 Sep; 27(1):111. PubMed ID: 34530732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.